Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methylplus is a dietary supplement formulated to support the body's methylation processes, which are essential for DNA synthesis, neurotransmitter production, and the detoxification of homocysteine. The formulation typically contains biologically active, pre-methylated forms of essential B-vitamins, including methylcobalamin (Vitamin B12), 5-methyltetrahydrofolate (5-MTHF), and pyridoxal-5-phosphate (Vitamin B6), alongside methyl donors such as trimethylglycine (betaine). By providing these specific vitamers, Methylplus bypasses the metabolic steps required to convert synthetic vitamins into their active forms, which is particularly relevant for individuals with genetic polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) enzyme. Its primary application is the management of healthy homocysteine levels and the support of cardiovascular and neurological health through the optimization of the methionine cycle.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Methylplus.